title: Dopamine-secreting giant adrenal ganglioneuroma: clinical and diffusion-weighted magnetic resonance imaging findings.
abstract: We report a case of a dopamine-secreting giant primary adrenal ganglioneuroma (GN) in a 29-year-old male patient. Although the patient was clinically silent, the 24-hour urine levels of dopamine, normetanephrine, homovanillic acid and vanillyl mandelic acid were elevated. Abdominal ultrasonography and magnetic resonance imaging showed a large solid tumor with calcifications and a slightly lobular edge on the left adrenal gland. A tumor, 13 x 23 x 25 cm in size, was completely resected without morbidity. A 2-year follow-up with computed tomography showed that the postoperative course of the patient was uneventful.
authors: A V
authors: AV
authors: Polat
authors: A Kamali
authors: AK
authors: Polat
authors: K
authors: K
authors: Aslan
authors: H
authors: H
authors: Atmaca
authors: F
authors: F
authors: Karagoz
mesh_terms: D000310:Adrenal Gland Neoplasms / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D000311:Adrenal Glands / Q000000981:diagnostic imaging* / Q000473:pathology* / Q000601:surgery; D000328:Adult; D003287:Contrast Media; D003937:Diagnosis, Differential; D038524:Diffusion Magnetic Resonance Imaging / Q000379:methods*; D004298:Dopamine / Q000378:metabolism*; D005500:Follow-Up Studies; D005682:Gadolinium; D005729:Ganglioneuroma / Q000175:diagnosis* / Q000378:metabolism / Q000601:surgery; D006801:Humans; D007089:Image Enhancement / Q000379:methods; D008297:Male; D016896:Treatment Outcome; D014463:Ultrasonography
chemical_list: D003287:Contrast Media; D005682:Gadolinium; D004298:Dopamine